Les gènes modificateurs dans les maladies héréditaires

[1]  E. Lander,et al.  Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse , 1993, Cell.

[2]  C. Beaumont,et al.  Modulation of the phenotype in dominant erythropoietic protoporphyria by a low expression of the normal ferrochelatase allele. , 1996, American journal of human genetics.

[3]  R. Fisher.  The Evolution of Dominance in Certain Polymorphic Species , 1930, The American Naturalist.

[4]  L. Tsui,et al.  A mutation in CFTR produces different phenotypes depending on chromosomal background , 1993, Nature Genetics.

[5]  J. Melki,et al.  The role of the SMN gene in proximal spinal muscular atrophy. , 1998, Human molecular genetics.

[6]  R. Carrell,et al.  A NEW DOUBLY SUBSTITUTED SICKLING HAEMOGLOBIN: HbS‐OMAN , 1989, British journal of haematology.

[7]  J. Haldane.  The relative importance of principal and modifying genes in determining some human diseases , 1941 .

[8]  Eric S. Lander,et al.  Secretory phospholipase Pla2g2a confers resistance to intestinal tumorigenesis , 1997, Nature Genetics.

[9]  M. Komajda,et al.  The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. , 1997, Journal of molecular and cellular cardiology.

[10]  M. Vidaud,et al.  Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Lathrop,et al.  Dissecting the loci controlling fetal haemoglobin production on chromosomes 11p and 6q by the regressive approach , 1996, Nature Genetics.

[12]  P Brown,et al.  Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. , 1992, Science.

[13]  L. Tsui,et al.  Erratum: Modulation of disease severity in cystic fibrosis transmembrane conductance regulator deficient mice by a secondary genetic factor (Nature Genetics (1996) 12 (280-287)) , 1996 .

[14]  A. Baldini,et al.  Mutations in LMX1B cause abnormal skeletal patterning and renal dysplasia in nail patella syndrome , 1998, Nature Genetics.

[15]  K. Summers.  Relationship between genotype and phenotype in monogenic diseases: Relevance to polygenic diseases , 1996, Human mutation.

[16]  Xavier Estivill,et al.  Complexity in a monogenic disease , 1996, Nature Genetics.

[17]  B. Theophilus,et al.  Complex alleles of the acid beta-glucosidase gene in Gaucher disease. , 1990, American journal of human genetics.

[18]  U. Wolf.  Identical mutations and phenotypic variation , 1997, Human Genetics.

[19]  D. Labie,et al.  Modulation polygénique des maladies monogéniques : l'exemple de la drépanocytose , 1996 .

[20]  I. Tomlinson,et al.  Modifier genes in humans: strategies for identification , 1998, European Journal of Human Genetics.

[21]  T. L. McGee,et al.  Evidence that the penetrance of mutations at the RP11 locus causing dominant retinitis pigmentosa is influenced by a gene linked to the homologous RP11 allele. , 1997, American journal of human genetics.

[22]  J. Renwick.  NAIL‐PATELLA SYNDROME: EVIDENCE FOR MODIFICATION BY ALLELES AT THE MAIN LOCUS , 1956, Annals of human genetics.

[23]  R J Adams,et al.  Alpha thalassemia and stroke risk in sickle cell anemia , 1994, American journal of hematology.

[24]  A. Munnich,et al.  Age-related macular degeneration in grandparents of patients with Stargardt disease: genetic study. , 1999, American journal of ophthalmology.

[25]  M. Goossens,et al.  Polyvariant mutant cystic fibrosis transmembrane conductance regulator genes. The polymorphic (Tg)m locus explains the partial penetrance of the T5 polymorphism as a disease mutation. , 1998, The Journal of clinical investigation.